Effects of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina
JC Kaski,
G Rosano,
S Gavrielides,
and
L Chen
Department of Cardiological Sciences, St. George's Hospital Medical School, London, England, United Kingdom.
OBJECTIVES. This study was conducted to test the hypothesis that angiotensin-converting enzyme inhibition may lessen myocardial ischemia in patients with microvascular angina. BACKGROUND. Patients with syndrome X (angina pectoris, positive findings on exercise testing and normal coronary arteriogram) have a reduced coronary vasodilator reserve ("microvascular angina") and may show an increased sympathetic drive. Angiotensin-converting enzyme inhibition attenuates sympathetic coronary vasoconstriction in patients with coronary artery disease. METHODS. Ten patients (seven women and three men, mean age [+/- SD] 53 +/- 6 years) with syndrome X and a reduced coronary flow reserve underwent a randomized, single-blind, crossover, placebo-controlled study of the effects of the angiotensin-converting enzyme inhibitor enalapril on angina and exercise-induced ST segment depression. Assessment was by symptom-limited treadmill exercise testing after 2 weeks of treatment with 10 mg/day of enalapril and after 2 weeks of placebo administration. RESULTS. All patients had positive findings on exercise testing (> or = 1 mm ST segment depression and angina) while taking placebo, whereas six patients had a positive test result (four with angina) during enalapril therapy. Total exercise duration and time to 1 mm of ST segment depression were prolonged by enalapril over those obtained with placebo (mean 779 +/- 141 vs. 690 +/- 148 s, p = 0.006 and 690 +/- 204 vs. 485 +/- 241 s, p = 0.007, respectively). The magnitude of ST segment depression was also less with enalapril than with placebo (mean 1.1 +/- 0.4 vs. 1.5 +/- 0.2 mm, p = 0.004). Heart rate and blood pressure at peak exercise and at 1 mm of ST depression were not significantly different during placebo and enalapril treatment. CONCLUSIONS. Angiotensin-converting enzyme inhibition lessens exercise-induced ischemia in patients with syndrome X and microvascular angina, probably by a direct modulation of coronary microvascular tone, which results in an increased myocardial oxygen supply.
This article has been cited by other articles:

|
 |

|
 |
 
G. A. Lanza and F. Crea
Primary Coronary Microvascular Dysfunction: Clinical Presentation, Pathophysiology, and Management
Circulation,
June 1, 2010;
121(21):
2317 - 2325.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. O. Cannon III
Microvascular Angina and the Continuing Dilemma of Chest Pain With Normal Coronary Angiograms
J. Am. Coll. Cardiol.,
September 1, 2009;
54(10):
877 - 885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Phan, C. Shufelt, and C. N. B. Merz
Persistent Chest Pain and No Obstructive Coronary Artery Disease
JAMA,
April 8, 2009;
301(14):
1468 - 1474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J Russell, E. M Di Stefano, M. T Naffati, O. Brown, and S. Saltissi
The effects of the angiotensin II receptor (type I) antagonist irbesartan in patients with cardiac syndrome X
Heart,
February 1, 2007;
93(2):
253 - 254.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Danchin, M. Cucherat, C. Thuillez, E. Durand, Z. Kadri, and P. G. Steg
Angiotensin-Converting Enzyme Inhibitors in Patients With Coronary Artery Disease and Absence of Heart Failure or Left Ventricular Systolic Dysfunction: An Overview of Long-term Randomized Controlled Trials.
Arch Intern Med,
April 10, 2006;
166(7):
787 - 796.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Pepine, J.-L. Rouleau, K. Annis, A. Ducharme, P. Ma, J. Lenis, R. Davies, U. Thadani, B. Chaitman, H. E. Haber, et al.
Effects of angiotensin-converting enzyme inhibition on transient ischemia: The quinapril anti-ischemia and symptoms of angina reduction (QUASAR) trial
J. Am. Coll. Cardiol.,
December 17, 2003;
42(12):
2049 - 2059.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Kaski and L. F. Valenzuela Garcia
Therapeutic options for the management ofpatients with cardiac syndrome X
Eur. Heart J.,
February 2, 2001;
22(4):
283 - 293.
[PDF]
|
 |
|

|
 |

|
 |
 
N.-W. Hsu, J.-W. Chen, S.-L. Jen, B. I.-T. Kuo, W.-L. Lee, G.-Y. Mar, S.-J. Lin, S.-P. Wang, M.-S. Chang, and J.-W. Chen
Differentiating Syndrome X from Coronary Artery Disease by Treadmill Exercise Test in Patients with Chest Pain and Exercise-Induced Myocardial Ischemia
Angiology,
January 1, 1998;
49(1):
13 - 24.
[Abstract]
[PDF]
|
 |
|
|